The results revealed endogenous hyperinsulinemia, with insulin levels of 5.5 μU/mL (reference 2–3 μU/mL) and C-peptide levels of of 2.01 ng/mL (reference: 1.1–1.5 ng/mL) (see Table 1). The gene discussed is INS; the disease is hyperinsulinism.